If you or the patients you represent have adverse events, adverse reactions and other drug safety issues after using our products, we recommend that you first consult a healthcare professional before reporting to us. Because industry regulations do not allow pharmaceutical companies to provide diagnostic information or advice to patients about diseases or treatment options, we may not be able to make specific recommendations about your current condition, but we will carefully respond to any inquiries you may have about the safety of our products.

How should you report drug safety information to us?

You can report or consult questions related to the safety of our products through the following two ways of contact. Our pharmacovigilance team will be happy to provide you with professional, efficient and high-quality pharmacovigilance services. We would like to thank you for your reported security information and suggestions.

Pharmacovigilance hotline: 0551-62651048
Pharmacovigilance public email: JXPV@jxpharm.vip